New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Microbot Medical Inc.

Contributing Author

Recent Articles by Microbot Medical Inc.

Sep-16	Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds MBOT GlobeNewswire
Sep-15	Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds MBOT GlobeNewswire
Sep-09	REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference MBOT GlobeNewswire
Sep-08	Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System MBOT GlobeNewswire
Aug-20	Microbot Medical Granted U.S. Patent that Significantly Expands Potential Market Applications MBOT GlobeNewswire
Aug-05	Microbot Medical Receives Non-Dilutive Grant to Enhance Operational Capabilities MBOT GlobeNewswire
Jul-22	Microbot Medical Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales MBOT GlobeNewswire
Jul-08	Microbot Medical to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting MBOT GlobeNewswire
Jun-30	Microbot Medical Added to the Russell Microcap Index MBOT GlobeNewswire
Jun-17	Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China MBOT GlobeNewswire
Jun-09	Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY Endovascular Robotic System MBOT GlobeNewswire
Jun-05	Microbot Medical Selected for Preliminary Inclusion to Russell Microcap Index MBOT GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.